Postpartum Sexual Function in Pregnant Women With COVID-19

Completed

• Conditions: Dyspareunia; Postpartum Period; COVID-19

• Registration Number: NCT04389489
• Lead Sponsor: Kanuni Sultan Suleyman Training and Research Hospital

Brief Summary

The aim of this study is to identify women with postpartum sexual dysfunction and dyspareunia risk in the early period and to use the treatment and care services they need effectively. Our secondary aim is to reveal the difference in sexual life in the postpartum period between healthy pregnant women and pregnant women diagnosed with COVID-19.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-05-14
• Study First Submitted: 2020-05-14
• Study First Submitted QC: 2020-05-14
• Study First Posted: 2020-05-15
• Primary Completion: 2020-09-25
• Study Completion: 2020-09-30
• Status Verified: 2023-03
• Last Update Submitted: 2023-03-28
• Last Update Posted: 2023-03-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 140

Inclusion Criteria

• Pregnant Patient with COVID-19

Read More

Exclusion Criteria

• Those with known sexual dysfunction disorder

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evaluation of pregnant women diagnosed with COVID-19 using Carol Postpartum Sexual Function and Dyspareunia Scale	3 months	In the study planned to be carried out, it is aimed to identify women at risk of postpartum sexual dysfunction and dyspareunia early and benefit from the treatment and care services they need effectively.

Secondary Outcome Measures

Name	Time	Method
Evaluation of pregnant women diagnosed with COVID-19 using Carol Postpartum Sexual Function and Dyspareunia Scale	3 Months	To reveal the difference in sexual life in postpartum period between healthy pregnant women and pregnant women diagnosed with COVID-19.

Trial Locations

Locations (1)

Kanuni Sultan Suleyman Training and Research Hospital; 🇹🇷 Istanbul, Halkali, Turkey